Hong Kong Stock Movement | CONANT OPTICAL (02276) Rises Over 5% as Meta Plans to Double AI Smart Glasses Production Capacity; Company Benefits from Accelerated Industry Chain Development

Stock News
01/14

CONANT OPTICAL (02276) rose over 5%, and as of the time of writing, it was up 5.36%, trading at HKD 55.05 with a turnover of HKD 27.6336 million. On the news front, Meta Platforms and EssilorLuxottica are reportedly discussing a plan to double the production capacity of AI smart glasses by the end of this year, aiming to capture growing demand and establish a presence ahead of competitors. According to informed sources, as sales of the Ray-Ban Meta smart glasses gradually ramp up, Meta has proposed increasing the annual production capacity to 20 million units or more by the end of 2026. Guotai Haitong Securities noted in a research report that, according to Counterpoint Research, global smart glasses shipments in the first half of 2025 increased by 110% year-on-year, maintaining rapid growth. The inclusion of smart glasses in national subsidies for the first time is expected to bring incremental demand. Huachuang Securities stated in its research report that CONANT OPTICAL has deep roots in the eyewear manufacturing industry, with simultaneous progress in domestic and international sales, and that structural upgrades are expected to drive continuous improvement in profitability. The company has already collaborated with several leading 3C manufacturers to develop smart glasses, indicating promising growth prospects. Considering the accelerated development of the smart glasses industry chain coupled with the steady upward trend in the company's product mix, the brokerage forecasts the company's net profit attributable to parents for 2025-2027 to be RMB 560 million, RMB 700 million, and RMB 870 million, respectively, corresponding to a PE ratio of 41x, 34x, and 27x.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10